1. Home
  2. TECX vs SHAZ Comparison

TECX vs SHAZ Comparison

Compare TECX & SHAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$33.99

Market Cap

393.0M

Sector

N/A

ML Signal

N/A

SHAZ

SharonAI Holdings Inc. Class A Common Stock

N/A

Current Price

$18.22

Market Cap

284.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
SHAZ
Founded
2019
2024
Country
United States
United States
Employees
51
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
284.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
SHAZ
Price
$33.99
$18.22
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$80.40
N/A
AVG Volume (30 Days)
552.9K
162.2K
Earning Date
01-01-0001
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$16.55
52 Week High
$35.99
$31.95

Technical Indicators

Market Signals
Indicator
TECX
SHAZ
Relative Strength Index (RSI) 75.47 12.20
Support Level $16.83 $16.55
Resistance Level N/A $20.60
Average True Range (ATR) 2.45 2.48
MACD 1.27 -1.10
Stochastic Oscillator 87.37 12.66

Price Performance

Historical Comparison
TECX
SHAZ

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SHAZ SharonAI Holdings Inc. Class A Common Stock

SharonAI Holdings Inc is a high-performance computing (HPC) company deploying large-scale energy and compute infrastructure, USA energy markets and infrastructure asset management. Its services include: Sovereign AI Australia, GPU-as-a-Service, SHARON AI Cloud, SHARON AI Private Cloud, Virtual Private Clusters, HPC Servers, SHARON AI Supercluster, GPU Fleet, Virtual Servers, Cloud Storage, AI Model Training, High-Performance Computing (HPC), and Video Encoding & Decoding. The company's products are: Sovereign AI Australia, GPU-as-a-Service, SHARON AI Cloud, SHARON AI Private Cloud, Virtual Private Clusters, HPC Servers, SHARON AI Supercluster, GPU Fleet, Virtual Servers, Cloud Storage, AI Model Training, High Performance Computing (HPC), and Video Encoding & Decoding.

Share on Social Networks: